CIHR Fellowship
2019: Awarded to Dr. Flory Muanda for the project "Preventing medication errors in patients with low kidney function."
ICES brings together the best and brightest scientific talent. Many of our scientists are internationally recognized in their fields and receive national and international awards and recognition for their important work.
2019: Awarded to Dr. Flory Muanda for the project "Preventing medication errors in patients with low kidney function."
2018: Awarded to Dr. Flory Muanda for the paper "Use of antibiotics during pregnancy and the risk of major congenital malformations: A population-based cohort study". The prize is awarded to the best paper published in BJCP during an academic year. Read more
2018: Awarded to Dr. Phillip Blanchette by the Oncology Department, Schulich School of Medicine & Dentistry, Western University.
2018: Awarded to Dr. Janice Tijssen by the Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University.
2017: Awarded to Dr. Jacques Raphael for the paper "Palbociclib in hormone receptor positive advanced breast cancer: a cost-utility analysis."
2016: Awarded to Dr. Amit Garg. Every year, the Young Investigator Award is presented to one individual 45 years of age or younger “with an outstanding record of achievement and creativity in basic or patient-oriented research related to the functions and diseases of the kidney.”
2016: Awarded to Team Western, including Dr. Kristin Clemens for the best answer to the question "To what extent does re-prescribing and re-dispensing of culprit drugs contribute to the burden of adverse drug events presenting to Canadian hospitals?" and the Judges Choice Award.
2015 – 2018: Awarded to Dr. Kelly Anderson for Health Service Use and Outcomes for People with First-Episode Psychosis in Ontario by the Ontario Mental Health Foundation.
2015-2018: Awarded to Dr. Danielle Nash by CIHR-IHSPR.
2015: Awarded to Dr. Jacques Raphael for the paper "Effect of tumor infiltrating lymphocytes and stromal CD68 on trastuzumab benefit in early stage HER2 positive breast cancer."